SIRPA and cancer: Flow cytometry analysis after incubation revealed enhanced phagocytic activity in macrophages co-cultured with MφNP-treated cancer cells compared to those cultured with SIRPα-blocked MφNPs or plain nanoparticles (Fig. S2).